Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Plerixafor

A CXCR4 receptor antagonist that releases blood stem cells from the bone marrow, approved in the United States in 2008 to collect them before autologous transplant in patients with non-Hodgkin lymphoma or multiple myeloma. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It was born as an anti-HIV drug, since HIV uses CXCR4 to enter cells: the first bicyclam of the family was found by chance as an impurity in a commercial sample of cyclam.

PlerixaforGo to the active ingredient →
PlerixaforActive ingredientPlerixaforCat. No. P-P148-001CAS 110078-46-1
Plerixafor-d4Isotopically labelledPlerixafor-d4Cat. No. P-P148-002CAS 1246819-87-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.